These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1883046)

  • 1. [Our experience with the use of the new Bulgarian intrauterine contraceptive device, the Venus Cu 300 (preliminary report)].
    Vasilev D; Vlasova D; Filipov S; Bozhilov D; Nalbanski V; Katsarova M; Dimitrova V
    Akush Ginekol (Sofiia); 1991; 30(2):39-43. PubMed ID: 1883046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with the Copper-7 and Copper-T intrauterine devices at Siriraj Hospital in Bangkok, Thailand.
    Koetsawang S; Srisupandit S; Bhiraleus P; Rachawat D; Kiriwat O; Jirochkul V; Mitra M; Thomas M
    J Med Assoc Thai; 1982 Jan; 65(1):12-7. PubMed ID: 6153035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nova-T and Copper-T 200 in a five year's clinical comparison].
    Nygren KG; Allonen H; Nielsen NC; Luukkainen T; Pyorala T
    Contracept Fertil Sex (Paris); 1983 Nov; 11(11):1179-84. PubMed ID: 12312701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six years' experience with the T Cu 220C intrauterine contraceptive device.
    Van Der Pas H; Thiery M; Delbeke L; Van Kets H; Haspels A
    Contracept Deliv Syst; 1980 Jan; 1(1):1-10. PubMed ID: 12261713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two IUDs: Multiload Cu 250 and Copper T 200.
    Ladehoff P; Hansen MK; Larsen S; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1983 Jan; 4(1):9-13. PubMed ID: 12264721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of side-effects of Cu-T as intra-uterine contraceptive device in post medical termination of pregnancy and interval cases.
    Das CR; Pradhan G
    J Indian Med Assoc; 1995 Oct; 93(10):375-6. PubMed ID: 9053409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD].
    Elia D; Belaisch J
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
    Roy S; Azen C
    Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of ethnic monitoring in the experience of Haringey Healthcare NHS trust community family planning clinics.
    Christopher E
    Br J Fam Plann; 1999 Jan; 24(4):123-7. PubMed ID: 10023096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim insertion of the ML Cu 250 intrauterine contraceptive device.
    Vankets He Thiery M; Van Der Pas H; Delbeke L Van Os WA; Tauber PE; Dombrowicz N; Macdonald JS; Haspels AA; Drogenduk AC
    Contracept Deliv Syst; 1980 Apr; 1(2):149-54. PubMed ID: 12336242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Copper-silver T: The classic T resuscitated].
    Jarvela S; Allonen H
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):45-7. PubMed ID: 12341240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three years experience with copper T-200.
    Kanitkar SD; Tare VS; Tambay PY; Mutatkar KR
    J Indian Med Assoc; 1983 May; 80(9-10):148-9. PubMed ID: 6644055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper IUDs.
    Thiery M
    Contracept Deliv Syst; 1983 Jul; 4(3):175-85. PubMed ID: 12265360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative study of the efficacy, tolerance and side effects in using IUDs--the Copper T and Nova T--over a 3-year period].
    Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(2):46-9. PubMed ID: 2400059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system.
    Delbarge W; Bátár I; Bafort M; Bonnivert J; Colmant C; Dhont M; Fonzé V; Gevers R; Janssens D; Lavalley P; Salmin E; Degueldre M; Vrijens M; Van Kets H; Wildemeersch D
    Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):24-30. PubMed ID: 12041861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the performance of a copper intrauterine device: MLCu 375].
    Audebert A; Emperaire JC; Larue-charlus S
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1):13-6. PubMed ID: 12266608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.